Investigators will study approximately 64 patients with Treatment-Resistant Bipolar
Depressive Disorder, defined as a failure of at least 1 antidepressants in the current
depressive episode and 2 lifetime medication failures. The study will last approximately 6 to
8 weeks, involving randomization into one of two treatment groups receiving 3 one hour long
inhalation treatments over a week.